Testosterone Injury Claims Move to Multidistrict Litigation
Posted on Monday, June 9th, 2014 at 11:56 am
In January, the U.S. Food and Drug Administration (FDA) announced that it had begun an investigation of a possible link between the use of testosterone replacement therapies and a range of serious health concerns, including heart attack and stroke. Soon afterwards, dozens of lawsuits were filed against the manufacturers of popular low testosterone treatments, including Androgel, Androderm, and others.
In order to streamline the litigation process, these suits have now been brought together as a multidistrict litigation in the Northern District of Illinois, which is where the majority of the initial claims originated. This will allow for a quicker process in helping those who may have been badly injured or who may have lost a loved one as a result of testosterone supplement use. You can read more about the multidistrict litigation by clicking here and here.
At Williams Hart, we are committed to holding pharmaceutical companies accountable when their products cause customers to suffer serious harm or injury, and we are prepared to offer our legal services to those who may have been harmed by the use of testosterone supplements. Contact us today at (800) 220-9341 to learn more about what our testosterone supplement lawyers can do for you.